Randomized trials in moderate ischemic mitral regurgitation: Many questions, limited answers

Circulation

Volumn 126, Issue 21, 2012, Pages 2452-2455

  O'Gara, Patrick T ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; MYOCARDIAL ISCHEMIA;

EID: 84869862560     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.146068     Document Type: Review

References (33)

1. Lamas GA, Mitchell GF, Flaker GC, Smith SC Jr, Gersh BJ, Basta L, Move L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation. 1997;96:827- 833. (Pubitemid 27329616)
2. Grigioni F, Enriquez-Sarano M, Zehr KJ, Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759 -1764. (Pubitemid 32291413)
3. Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Heart Failure and Death After Myocardial Infarction in the Community: The Emerging Role of Mitral Regurgitation. Circulation. 2005;111:295-301. (Pubitemid 40165335)
4. Rossi A, Dini FL, Faggiano P, Agricola E, Cicoira M, Frattini S, Simioniuc A, Gullace M, Ghio S, Enriquez-Sarano M, Temporelli PL. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischemic and non-ischemic dilated cardiomyopathy. Heart. 2011;97:1675-1680.
5. Dal-Bianco JP, Aikawa E, Bischoff J, Guerrero JL, Handschumacher MD, Sullivan S, Johnson B, Titus JS, Iwamoto Y, Wylie-Sears J, Levine RA, Carpentier A. Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation. Circulation. 2009;120:334-342.
6. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski, Stewart WJ, Waggoner A, Weissman NJ. Recommendations for the evaluation of the severity of native valvular regurgitation with twodimensional and Doppler echocardiography. J Am Soc Echocardiogr. 2003;16:777- 802. (Pubitemid 37391035)
7. Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Triboulloy C, Hagendorff A, Monin JL, Badano L, Zamorano JL. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11:307-332.
8. Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO. The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251-2260.
9. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Valvular Heart Disease). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/valvular/index.pdf.
10. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012).The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Available at: www.escardio.org/guidelines.
11. Bax JJ, Braun J, Somer ST, et al. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110:II-103-II-108. (Pubitemid 39263707)
12. Di Salvo TG, Acker MA, Dec GW, Byrne JG. Mitral Valve Surgery in Advanced Heart Failure. J Am Coll Cardiol. 2010;271-282.
13. Deja MA, Grayburn PA, Sun B, Rao V, She L, Krejca M, Jain AR, Leng Chua Y, Daly R, Senni M, Mokrzycki K, Menicanti L, Oh JK, Michler R, Wrobel K, Lamy A, Velazquez EJ, Lee KL, Jones RH. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation. 2012;125:2639 -2648.
14. Trento A, Goland S, De Robertis MA, Czer LS. Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation. J Thorac Cardiovasc Surg. 2009;138:286 -288.
15. Kwon MH, Cervasco M, Chen FY. Functional ischemic mitral regurgitation: to repair or not to repair? Circulation. 2012;125:2563-2565.
16. Penicka M, Linkova H, Lang O, Fojt R, Kocka V, Vanderheyden M, Bartunek J. Predictors of Improvement of Unrepaired Moderate Ischemic Mitral Regurgitation in Patients Undergoing Elective Isolated Coronary Artery Bypass Graft Surgery. Circulation. 2009;120:1474-1481.
17. Schroder JN, Williams ML, Hata JA, Muhlbaier LH, Swaminathan M, Mathew JP, Glower DD, O'Connor CM, Smith PK, Milano CA. Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting. Circulation. 2005;112(9 suppl):I293-I298. (Pubitemid 41268649)
18. McGee EC, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen G, Najam F, Shiota T, Sabik JF, Lytle BW, McCarthy PM, Cosgrove DM. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2004;128:916 -924. (Pubitemid 39575298)
19. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL; STICH Hypothesis 2 Investigators. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360: 1705-1717.
20. Lopes RD, Hafley GE, Allen KB, Ferguson TB, Peterson ED, Harrington RA, Mehta RH, Gibson CM, Mack MJ, Kouchoukos NT, Califf RM, Alexander JH. Endoscopic versus open vein-graft harvesting in coronaryartery bypass surgery. N Engl J Med. 2009;361:235-244.
21. Fattouch K, Guccione F, Sampognaro R, Panzarella G, Corrado E, Navarra E, Calvaruso D, Ruvolo G. Efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138:278 -285.
22. Chan KMJ, Punjabi PP, Flather MD, Wage R, Symmonds K, Roussin I, Rahman-Haley S, Pennell DJ, Kilner PJ, Dreyfus GD, Pepper JR; for the RIME Investigators. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation. 2012;126:2502-2510.
23. St. John Sutton MG, Plappert T, Abraham WT, Smith AL, DeLurgio DB, Leon AR, Loh E, Kocovic DZ, Fisher WG, Ellestad M, Messenger J, Kruger K, Hilpisch KE, Hill MR; Multicenter InSync Randomized Clinical Evaluation (MIRACLE) Study Group. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation. 2003;107:1985-1990. (Pubitemid 36506071)
24. Ypenburg C, Lancellotti P, Topps LF, Bleeker GB, Holman ER, Pierard LA, Schalij MJ, Bax JJ. Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation. J Am Coll Cardiol. 2007;50:2071-2077. (Pubitemid 350087580)
25. Van Bommel RJ, Marsan NA, Delgado V, Borleffs CJ, van Rijnsoever EP, Schalij MJ, Bax JJ. Cardiac resynchronization therapy as a therapeutic option in patients with moderate-severe functional mitral regurgitation and high operative risk. Circulation. 2011;124:912-919.
26. Bonow RO. Exercise hemodynamics and risk assessment in asymptomatic aortic stenosis. Circulation. 2012;126:803- 805.
27. Wierup P, Egebladh H, Nielsen SL, Schersten H, Kimblad PO, Bech-Hansen O, Roijer A, Nilsson F, McCarthy PM, Bouchard D, Jacobsen J, Johnsen SP, Poulsen SH, Molgaard H; MoMIC Trial Investigators. Moderate mitral regurgitation in patients undergoing CABG-the MoMIC Trial. Scand Cardiovasc J. 2009;43:50 -56.
28. Gardner TJ, O'Gara PT. The Cardiovascular Surgery Network: randomized clinical trials in the operating room. J Thor Cardiovasc Surg. 2010;139:830-834.
29. Perrault LP, Moskowitz AJ, Kron IL, et al. Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg. 2010;143:1396 -1403.
30. Smith PK, Michler RE, Woo YJ, Alexander JH, Puskas JD, Parides MK, Hahn RT, Williams JB, Dent JM, Ferguson TB Jr, Moguete E, Rose EA, Page P, Jeffries NO, O'Gara PT, Ascheim DD. Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: a report from the Cardiothoracic Surgical Trials Network. J Thorac Cardiovasc Surg. 2012;143:111-117.
31. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D, Treede H, Barmeyer A, Schofer J, Costard-Jackle A, Schluter M, Reichenspurner H, Meinertz T. Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction. Eur Heart J. 2010;31: 1373-1381.
32. Franzen O, van der Heyden J, Baldus S, Schluter M, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Rudolph V, Surder D, Grunenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A. MitraClip therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569 -576.
33. Clinical Outcomes Assessment of the MitraClip Percutaneous Therapy for High Surgical Risk Patients (COAPT). www.clinicaltrials.gov. NCT01626079.